May 17, 2019
Japanese major drug wholesaler Suzuken has entered into a distribution agreement with Novartis Pharma for the CAR-T cell therapy Kymriah (tisagenlecleucel) in Japan, the company said on May 16. Suzuken will solely distribute the product in the country. Under the...read more